PROCEPT BioRobotics Corp (PRCT)
68.16
+0.02
(+0.03%)
USD |
NASDAQ |
May 17, 16:00
65.00
-3.16
(-4.64%)
After-Hours: 20:00
PROCEPT BioRobotics Cash from Investing (TTM): -21.81M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -21.81M |
December 31, 2023 | -25.21M |
September 30, 2023 | -17.36M |
June 30, 2023 | -13.09M |
March 31, 2023 | -7.937M |
Date | Value |
---|---|
December 31, 2022 | -2.653M |
September 30, 2022 | -2.119M |
June 30, 2022 | -0.716M |
March 31, 2022 | -0.608M |
December 31, 2021 | -0.592M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-25.21M
Minimum
Dec 2023
-0.592M
Maximum
Dec 2021
-9.209M
Average
-5.295M
Median
Cash from Investing (TTM) Benchmarks
Intuitive Surgical Inc | -1.062B |
Integra Lifesciences Holdings Corp | -134.44M |
Masimo Corp | -89.00M |
Perspective Therapeutics Inc | -48.19M |
Xtant Medical Holdings Inc | -8.037M |